Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 193

1.

Travel medicine perspectives of select travel medicine experts practicing in the Asia-Pacific region.

Leder K, Borwein S, Chanthavanich P, Chatterjee S, Htun K, Marma ASP, Nakatani I, Ok JJ, Pakasi L, Pandey P, Piyaphanee W, Rupali P, Schwartz E, Shinozuka T, Phu PTH, Watanabe H, Visser J, Wilder-Smith A, Zhang M, McGuinness SL.

J Travel Med. 2017 Jul 1;24(4). doi: 10.1093/jtm/tax012. No abstract available.

PMID:
28426112
2.

Closing the gap in travel medicine: reframing research questions for a new era.

Chen LH, Leder K, Wilson ME.

J Travel Med. 2017 Jul 1;24(4). doi: 10.1093/jtm/tax001.

PMID:
28426110
3.

Management of dengue in Australian travellers: a retrospective multicentre analysis.

Tai AY, McGuinness SL, Robosa R, Turner D, Huang GK, Leder K, Korman TM, Thevarajan I, Stewardson AJ, Padiglione AA, Johnson DF.

Med J Aust. 2017 Apr 17;206(7):295-300.

PMID:
28403751
4.

Travellers' diarrhoea-a survey of practice.

McGrath CM, Leder K.

J Travel Med. 2017 Mar 1;24(2). doi: 10.1093/jtm/taw085.

PMID:
28395092
5.

Use of pre-travel vaccine-preventable disease serology as a screening tool to identify patients in need of pre-travel vaccination: a retrospective audit.

Turner DP, McGuinness SL, Cohen J, Waring LJ, Leder K.

J Travel Med. 2017 May 1;24(3). doi: 10.1093/jtm/tax011.

PMID:
28355621
6.

Protocol for a cluster randomised stepped wedge trial assessing the impact of a community-level hygiene intervention and a water intervention using riverbank filtration technology on diarrhoeal prevalence in India.

McGuinness SL, O'Toole JE, Boving TB, Forbes AB, Sinclair M, Gautam SK, Leder K.

BMJ Open. 2017 Mar 17;7(3):e015036. doi: 10.1136/bmjopen-2016-015036.

7.

Timing of influenza vaccination in an Australian community-based surveillance system, 2010-2014.

Coghlan B, Carlson S, Leder K, Dalton C, Cheng AC.

Commun Dis Intell Q Rep. 2016 Sep 30;40(3):E347-E350. No abstract available.

PMID:
28278408
8.

AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol.

Eisen DP, Moore EM, Leder K, Lockery J, McBryde ES, McNeil JJ, Pilcher D, Wolfe R, Woods RL.

BMJ Open. 2017 Jan 20;7(1):e013636. doi: 10.1136/bmjopen-2016-013636.

9.

A practical approach to vaccination of patients with autoimmune inflammatory rheumatic diseases in Australia.

Wong PKK, Bagga H, Barrett C, Hanrahan P, Johnson D, Katrib A, Leder K, Marabani M, Pentony P, Riordan J, White R, Young L.

Intern Med J. 2017 May;47(5):491-500. doi: 10.1111/imj.13371. Review.

PMID:
28101910
10.

Australia's National Notifiable Diseases Surveillance System 1991-2011: expanding, adapting and improving.

Gibney KB, Cheng AC, Hall R, Leder K.

Epidemiol Infect. 2017 Apr;145(5):1006-1017. doi: 10.1017/S0950268816002752. Epub 2017 Jan 9.

PMID:
28065205
11.

Quantifying the Dynamics of Field Cancerization in Tobacco-Related Head and Neck Cancer: A Multiscale Modeling Approach.

Ryser MD, Lee WT, Ready NE, Leder KZ, Foo J.

Cancer Res. 2016 Dec 15;76(24):7078-7088. Epub 2016 Oct 20.

PMID:
27913438
12.

Spatial Measures of Genetic Heterogeneity During Carcinogenesis.

Storey K, Ryser MD, Leder K, Foo J.

Bull Math Biol. 2017 Feb;79(2):237-276. doi: 10.1007/s11538-016-0234-5. Epub 2016 Nov 30.

PMID:
27905065
13.

Travel-Associated Zika Virus Disease Acquired in the Americas Through February 2016: A GeoSentinel Analysis.

Hamer DH, Barbre KA, Chen LH, Grobusch MP, Schlagenhauf P, Goorhuis A, van Genderen PJ, Molina I, Asgeirsson H, Kozarsky PE, Caumes E, Hagmann SH, Mockenhaupt FP, Eperon G, Barnett ED, Bottieau E, Boggild AK, Gautret P, Hynes NA, Kuhn S, Lash RR, Leder K, Libman M, Malvy DJ, Perret C, Rothe C, Schwartz E, Wilder-Smith A, Cetron MS, Esposito DH; GeoSentinel Surveillance Network.

Ann Intern Med. 2017 Jan 17;166(2):99-108. doi: 10.7326/M16-1842. Epub 2016 Nov 22.

PMID:
27893080
14.

Sociodemographic and geographical inequalities in notifiable infectious diseases in Australia: a retrospective analysis of 21 years of national disease surveillance data.

Gibney KB, Cheng AC, Hall R, Leder K.

Lancet Infect Dis. 2017 Jan;17(1):86-97. doi: 10.1016/S1473-3099(16)30309-7. Epub 2016 Oct 24.

PMID:
27789179
15.

Global malaria importations.

Leder K, Chen LH.

Lancet Infect Dis. 2017 Jan;17(1):11-12. doi: 10.1016/S1473-3099(16)30404-2. Epub 2016 Oct 21. No abstract available.

16.

Overwhelming post-splenectomy sepsis in patients with asplenia and hyposplenia: a retrospective cohort study.

Chong J, Jones P, Spelman D, Leder K, Cheng AC.

Epidemiol Infect. 2017 Jan;145(2):397-400. Epub 2016 Oct 25.

PMID:
27776576
17.

Optimized Treatment Schedules for Chronic Myeloid Leukemia.

He Q, Zhu J, Dingli D, Foo J, Leder KZ.

PLoS Comput Biol. 2016 Oct 20;12(10):e1005129. doi: 10.1371/journal.pcbi.1005129. eCollection 2016 Oct.

18.

An overview of the epidemiology of notifiable infectious diseases in Australia, 1991-2011.

Gibney KB, Cheng AC, Hall R, Leder K.

Epidemiol Infect. 2016 Nov;144(15):3263-3277. Epub 2016 Jun 22. Review.

PMID:
27586156
19.

Optimal treatment and stochastic modeling of heterogeneous tumors.

Badri H, Leder K.

Biol Direct. 2016 Aug 23;11:40. doi: 10.1186/s13062-016-0142-5. Review.

20.

Estimates of influenza vaccine coverage from Victorian surveillance systems based in the community, primary care and hospitals.

Coghlan B, Kelly HA, Carlson SJ, Grant KA, Leder K, Dalton CB, Cheng AC.

Commun Dis Intell Q Rep. 2016 Jun 30;40(2):E204-6. No abstract available.

Supplemental Content

Support Center